Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period
- PMID: 10516746
- DOI: 10.1038/sj.leu.2401544
Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period
Abstract
We reviewed the reports of 784 consecutive patients admitted to our department for newly diagnosed acute myeloid leukemia (AML) over a 16-year period. Median, 5-year and 10-year overall survivals were 9. 5 months, 17.3% and 11.7% respectively. Induction treatment (698 patients) resulted in 50% complete remissions (CR) (from 26.5% in secondary AML to 81.2% in patients <60 years with de novo AML). Period of diagnosis (1980-84/85-89/90-95) demonstrated a major significance for CR achievement and OS in multivariate analysis. In patients >/=60 years (372), CR rate increased (25% to 36.8%, P = 0. 03), and 5-year OS (3.7% to 10.6%, P = 0.022) improved, probably due to an increase in the proportion of patients administered conventional combined chemotherapy (54.5% to 83.8%, P < 0.0001). In younger patients CR rate continuously increased (61.5% to 74.8%, P = 0.028) with an associated improvement of 5-year OS (19.2% to 35.4%). No significant change in DFS and CR durations was observed. This large single center study on a large cohort of unselected AML patients reflects the improvement achieved in the management of AML patients, likely due to improvement of supportive care practices, administration of conventional induction to more elderly patients, and intensification of induction and post-remission treatments in patients <60 years.
Similar articles
-
Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience.Sao Paulo Med J. 2000 Nov 9;118(6):173-8. doi: 10.1590/s1516-31802000000600005. Sao Paulo Med J. 2000. PMID: 11120548 Free PMC article. Clinical Trial.
-
Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective study.Ann Hematol. 2003 Jul;82(7):381-9. doi: 10.1007/s00277-003-0650-0. Epub 2003 May 20. Ann Hematol. 2003. PMID: 12756497
-
Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemia.Leuk Res. 2001 Aug;25(8):685-92. doi: 10.1016/s0145-2126(01)00006-6. Leuk Res. 2001. PMID: 11397474
-
Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia.Leukemia. 1999 Jun;13(6):843-9. doi: 10.1038/sj.leu.2401445. Leukemia. 1999. PMID: 10360370 Clinical Trial.
-
A systematic overview of chemotherapy effects in acute myeloid leukaemia.Acta Oncol. 2001;40(2-3):231-52. doi: 10.1080/02841860151116321. Acta Oncol. 2001. PMID: 11441935 Review.
Cited by
-
Can the Gene Expression Profile of Patients with Acute Myeloid Leukemia Predict Complete Remission Following Induction Therapy?J Cancer. 2022 Feb 14;13(4):1356-1362. doi: 10.7150/jca.57457. eCollection 2022. J Cancer. 2022. PMID: 35281876 Free PMC article.
-
Transplant Eligible and Ineligible Elderly Patients with AML-A Genomic Approach and Next Generation Questions.Biomedicines. 2024 Apr 29;12(5):975. doi: 10.3390/biomedicines12050975. Biomedicines. 2024. PMID: 38790937 Free PMC article. Review.
-
Targeting CD47/SIRPα in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Preclinical and Clinical Developments of Magrolimab.J Immunother Precis Oncol. 2021 May 14;4(2):67-71. doi: 10.36401/JIPO-21-X2. eCollection 2021 May. J Immunother Precis Oncol. 2021. PMID: 35663535 Free PMC article. No abstract available.
-
New directions for emerging therapies in acute myeloid leukemia: the next chapter.Blood Cancer J. 2020 Oct 30;10(10):107. doi: 10.1038/s41408-020-00376-1. Blood Cancer J. 2020. PMID: 33127875 Free PMC article. Review.
-
An Update on Immune Based Therapies in Acute Myeloid Leukemia: 2021 and Beyond!Adv Exp Med Biol. 2021;1342:273-295. doi: 10.1007/978-3-030-79308-1_9. Adv Exp Med Biol. 2021. PMID: 34972969
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources